awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28076911-CD1B4323-60D5-4017-A6E7-BC0EEF05A5B0
Q28076911-CD1B4323-60D5-4017-A6E7-BC0EEF05A5B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076911-CD1B4323-60D5-4017-A6E7-BC0EEF05A5B0
Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives
P2860
Q28076911-CD1B4323-60D5-4017-A6E7-BC0EEF05A5B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076911-CD1B4323-60D5-4017-A6E7-BC0EEF05A5B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
586928e6f4f5efc243b203093b2e5184d83a217e
P2860
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.